Myelosuppression is a prominent side effect of MMF [11], and posaconazole is a known inhibitor of cytochrome P450 3A4 (CYP450) [12], which is one of several enzymes that metabolizes the active form of MMF into metabolites excreted in the urine. Here, CYP3A4 is linked to myelosuppression.